Comments
Loading...
Terns Pharma (TERN) Forecast
NewsEarningsTerns Pharma (TERN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTerns Pharma (NASDAQ:TERN) Stock Quotes, Forecast and News Summary
Terns Pharma Stock (NASDAQ: TERN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Terns Pharma (TERN) stock?
You can purchase shares of Terns Pharma (NASDAQ:TERN) through any online brokerage.
Who are Terns Pharma (TERN) competitors?
Other companies in Terns Pharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD) and GH Research (NASDAQ:GHRS).
What is the forecast, or price target, for Terns Pharma (TERN) stock?
Terns Pharma has a consensus price target of $16.75.
What is the current price for Terns Pharma (TERN)?
The stock price for Terns Pharma (NASDAQ: TERN) is $4.73 last updated January 22, 2025 at 2:35 PM EST.
Does Terns Pharma (TERN) pay a dividend?
There are no upcoming dividends for Terns Pharma.
When is Terns Pharma (NASDAQ:TERN) reporting earnings?
Terns Pharma’s Q4 earnings are confirmed for Thursday, March 13, 2025.
Is Terns Pharma (TERN) going to split?
There is no upcoming split for Terns Pharma.
What sector and industry does Terns Pharma (TERN) operate in?
Terns Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.